Reshaping fluids – a new microfluidics technology for biomedicine
Microfluidics deals with very small volumes of liquids (under 1µL). While cell biologists often manipulate tiny volumes, they do not normally use microfluidics due to the cost and complexity of manufacture, concerns with biocompatibility and the inaccessibility of cells once introduced into such enclosed spaces.
In a collaborative study between the Cook lab at the Dunn School of Pathology and the Walsh lab at the Department of Engineering Science, Soitu and colleagues have developed a revolutionary method for cell biologists to create microfluidic arrangements containing sub-microlitre volumes. They reshaped fluids on a substrate and exploited interfacial forces (or surface tension – the elastic tendency of a fluid surface to acquire the least surface area possible) at the microscale level. In this platform, liquids are confined within fluid (not solid) walls formed by the interface between water and an immiscible liquid (a fluorocarbon). These walls spontaneously seal around inserted pipettes, and self-heal when they are withdrawn. This method provides an accurate, simple and customisable approach for fabrication of microfluidic devices using materials that are familiar to biologists.
Soitu C, Feuerborn A, Tan AN, Walker H, Walsh PA, Castrejón-Pita AA, Cook PR, Walsh EJ (2018). Microfluidic chambers using fluid walls for cell biology
Proc Natl Acad Sci U S A.115(26):E5926-E5933.
Deciphering the mode of action of the influenza virus transcriptase
Curtailment of the spread of influenza virus has long been a subject of great interest and research. The influenza virus RNA polymerase performs both transcription and replication of the viral RNA genome. For transcription, it associates with host RNA polymerase II (Pol II) and steals nascent host capped RNA fragments that it uses as primers. Recent work has shown that the viral polymerase can assume multiple conformations, corresponding to different functional states, but much less is known about the factors that regulate these states and its mode of action.
With the aid of x-ray crystallography, cryo–electron microscopy, in vitro activity and cell based minireplicon assays, Serna Martin, Hengrung and colleagues set out to understand the mechanistic details of the interaction between host Pol II and the viral polymerase. Their investigations revealed that the interaction is important for stabilizing the transcriptase conformation of the viral polymerase and uncovered a binding site on the viral polymerase for Pol II. This binding site is crucial for influenza virus polymerase function, thus making it an attractive target for future anti-viral small molecule inhibitor development.
Serna Martin I, Hengrung N, Renner M, Sharps J, Martínez-Alonso M, Masiulis S, Grimes JM, Fodor E (2018). A Mechanism for the Activation of the Influenza Virus Transcriptase
Mol Cell. 70(6):1101-1110.e4
RNA/DNA interactome provides insight into R-loop regulation in health and disease
R-loops are unusual nucleic acid structures comprising both RNA and DNA components. They play key roles in the cell, for instance in DNA transcription and replication, but when mis-regulated they are associated with DNA damage and pathologies, including neurological disorders. Yet little is known about which factors are involved in R-loop regulation.
To address this, researchers from the Gromak lab used affinity purification and mass spectrometry to identify 469 proteins which interact with RNA/DNA hybrids (an ‘interactome’). This included helicases such as DHX9, whose role in R-loop biology had not been previously characterised. To validate hits from the interactome, Cristini and colleagues demonstrated that DHX9 helicase plays a role in suppressing the formation of R-loops and promoting the termination of transcription in vivo. They postulate that the helicase may travel along a gene, quelling R-loops as it travels. They also found that DHX9 acts to reduce DNA damage induced by R-loop accumulation.
Interestingly, DHX9 expression is overexpressed in cancer. Combined with their functional study, this highlights the value of the Gromak lab’s RNA/DNA interactome for investigating how R-loop regulation might contribute to human disease.
Cristini A*, Groh M*, Kristiansen MS, Gromak N (2018) RNA/DNA Hybrid Interactome Identifies DHX9 as a Molecular Player in Transcriptional Termination and R-Loop-Associated DNA Damage
Cell Reports 23(6): 1891–1905
Modulation of transcription termination during cell cycle
Terminating transcription, the process by which RNA is generated from a DNA template, is crucial to the normal functioning of cells. In budding yeast, transcription of many non-protein-coding RNAs is terminated by a distinct complex called NNS, which comprises three proteins — Nrd1, Nab3 and Sen1. The catalytic component of the complex, Sen1, is present at much lower numbers than Nrd1 and Nab3, raising questions as to how this complex can efficiently operate.
Hannah Mischo (Proudfoot Lab) and colleagues have demonstrated that Sen1 is regulated throughout the cell cycle. Sen1 levels increase in S and G2 phases, during which the cell duplicates its DNA and prepares for cell division respectively. In G1 phase, during which the cell grows and synthesises messenger RNA and proteins, Sen1 levels are lowered. This downregulation is carried out by the ubiquitin-proteasome system, in which proteins are tagged with ubiquitin and targeted for degradation. When the modulation of Sen1 is perturbed, cell survival is affected due to the toxicity caused by excessive termination of transcription. This study provided insights into the regulation of transcription termination during the cell cycle.
Mischo HE, Chun Y, Harlen KM, Smalec BM, Dhir S, Churchman LS and Buratowski S (2018). Cell-Cycle Modulation of Transcription Termination Factor Sen1.
Molecular Cell. 70(2): 312-326.e7.
Controlling centriole growth by a homeostatic clock
Centrioles are organelles that perform key functions during cell division -as part of centrosomes- and ciliogenesis. These small structures are duplicated in each cellular division via the growth of a daughter centriole from the side of its mother. While the regulation of centriole and centrosome number in cells has been well characterised, the mechanisms controlling centriole growth have remained elusive to date.
Aydogan and colleagues (Raff lab) have used live imaging of early fly embryos, coupled with quantitative tools, to report a novel function for Polo-like Kinase 4 (Plk-4) in regulating centriole size. They observed that Plk4 drives centriole growth by linearly promoting the addition of building blocks (Sas-6 molecules) onto the proximal side of daughter centrioles throughout early/mid S-phase and halting growth once centrioles have reached their correct size. This homeostatic clock role of Plk4 is attributed to its predicted suicidal activity – the more active the kinase is, the faster it triggers its own degradation. This study sheds light on an enzyme that acts as a clock to control centriole growth and proposes a novel mechanism for organelle size regulation.
Aydogan MG, Wainman A, Saurya S, Steinacker TL, Caballe A, Novak ZA, Baumbach J, Muschalik N, Raff JW. (2018). A homeostatic clock sets daughter centriole size in flies.
J Cell Biol. 217(4):1233-1248.
Maintaining Intestinal Epithelial Integrity During Inflammation Through Autophagy
Autophagy is an evolutionarily conserved “self-devouring” process by which cells may degrade intracellular components, and is particularly important for recycling intracellular materials during periods of stress or starvation. In addition, it is also important in other physiological roles, such as the intracellular immune response. Autophagy genes such as ATG16L1 have been associated with inflammatory bowel disease (IBD); however, it is not known how autophagy regulates tissue homeostasis in the inflamed intestine.
Dr. Johanna Pott and colleagues in the Maloy Lab use cell-specific knockouts of the ATG16L1 gene in mice and intestinal stem cell (IEC) organoids to discover that autophagy was required in IECs to limit TNF-induced apoptosis in the epithelium during inflammatory conditions. Their work highlights the important role of autophagy in maintaining barrier integrity, by limiting cell death to reduce inflammation, and reveals a link between apoptosis and autophagy in intestinal epithelial cells. Additionally, the study indicates the potential role of anti-TNF based treatments in IBD patients in boosting epithelial barrier integrity.
Pott J, Kabat AM, Maloy KJ. (2018). Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice.
Cell Host Microbe. 23(2):191-202.e4.
Structure-based design of chimeric antigens for multivalent protein vaccines
Vaccines against bacterial pathogens, mostly based on the pathogens’ toxins or capsules components, have been revolutionary for human kind. However, these approaches are not feasible for pathogens such as serogroup B Neisseria meningitidis – where vaccine development has been impeded by pathogen diversity, the inability to use capsule-based vaccines and technical difficulties of generating antigens from membrane-embedded proteins. A solution for this problem is critical due to the rise of multi-drug resistant bacteria.
Hollingshead and colleagues have begun to address this problem by engineering chimeric antigens (ChA) consisting of two different N. meningitidis proteins. ChAs contain the protein fHbp as a molecular scaffold on to which they have engineered a critical region, the VR2 loop, from the membrane-bound protein PorA. They found that the ChAs retain the architecture of fHbp and the VR2 loop. The ChAs were also able to successfully elicit protective immune responses in mice against both protein antigens.
This proof-in-principle study demonstrates that ChAs can present important parts of membrane-bound proteins to the immune system and initiate an immune response, opening the door to a new generation of multivalent vaccines.
Hollingshead S, Jongerius I, Exley RM, Johnson S, Lea SM and Tang CM (2018). Structure-based design of chimeric antigens for multivalent protein vaccines
Nat. Commun. 13;9(1):1051.
Nuclear re-localization of Dicer in primary mouse embryonic fibroblast nuclei following DNA damage
The endoribonuclease Dicer is an integral component of the RNA interference pathway. Dicer generates small RNA species that regulate post-transcriptional gene silencing in the cytoplasm. However, increasing evidence indicates that Dicer has additional, non-canonical roles in the nucleus. Previous localisation studies with over-expressed tagged Dicer, yield limited and inconclusive insight in to the regulatory principles of nuclear Dicer localisation. To address the controversy in the field, Burger and colleagues have begun to unravel the cellular mechanisms that determine Dicer’s localisation when Dicer levels are kept physiological.
This study, performed in mouse cells, ensured endogenous expression levels of tagged Dicer. Burger and colleagues firstly assessed the localisation of Dicer in unperturbed cells. They show that approximately 5% of Dicer molecules localise to the nucleus under physiological conditions. Upon induction of DNA damage, in particular double-strand breaks, they found a 2-3 fold increase in nuclear Dicer localization. Under these conditions, >90% of nuclear Dicer was phosphorylated in a PI3K-dependent manner. Their findings suggest that damage-induced PI3K-signaling establishes distinct populations of Dicer, hinting at novel functions and complex regulation of RNAi components.
Burger K, Gullerova M. (2018). Nuclear re-localization of Dicer in primary mouse embryonic fibroblast nuclei following DNA damage.
PLoS Genet. 14(2):e1007151.
A chemical on/off switch for DNA damage repair
Cells have a complex protein machinery that activates a repair response after detecting damaged DNA. One of the mechanisms used to regulate the function and localisation of these proteins is the addition of molecules onto their building blocks (amino acids) that modify their behaviour.
Work from Ivan Ahel’s lab, together with collaborators at the Max Planck Institute in Cologne (Germany), has revealed that serine is the preferred amino acid of a family of modifying enzymes responsible for ADP-ribosylation (ADPr) – a protein modification regulating cellular processes, including the vital activation of DNA repair responses at DNA breaks. Palazzo et al. used cell biology and biochemical approaches to show that serine residues of histones (proteins that package DNA) become the main ADPr sites after DNA damage. Together with their previous work identifying the ‘eraser’ of serine ADPr, which enables the process to be reversed, this shows how proteins involved in DNA damage repair can be switched on/off in different physiological and pathological conditions. This knowledge could be used to develop new cancer drugs regulating ADPr signals and, therefore, controlling DNA repair.
Palazzo L, Leidecker O, Prokhorova E, Dauben H, Matic I, Ahel I. (2018). Serine is the major residue for ADP-ribosylation upon DNA damage.
Elife;7. pii: e34334. doi: 10.7554/eLife.34334.
Getting Lipid Droplets in shape via Ldo proteins
Cells store excess of energy as fat in dedicated organelles called Lipid Droplets (LDs). How the size and number of these energy stores are regulated by metabolic signals remains largely unknown. Employing yeast as a model system, Teixeira et al, identify a group of Lipid droplet organisation (Ldo) proteins that regulate key components of LD biogenesis machinery. They also demonstrate that the relative abundance of Ldo proteins responds to metabolic signals which in turn feed onto LD shape and composition. Interestingly, this relationship gains special prominence during nutrient starvation, a condition that triggers consumption of energy stored in LDs. This study sheds light on a new dimension of LD behaviour and dynamics, which ultimately may help better understand various metabolic disorders such as diabetes and obesity.
Teixeira V, Johnsen L, Martínez-Montañés F, Grippa A, Buxó L, Idrissi FZ, Ejsing CS, Carvalho P (2018). Regulation of lipid droplets by metabolically controlled Ldo isoforms.
J Cell Biol. 217(1):127-138